J&J-MERCK’s MYLANTA IS NUMBER ONE ANTACID IN U.S. -- JOHNSON & JOHNSON; PRELIMINARY INJUNCTION REQUEST AGAINST RPR’s MAALOX PROMOTIONS DENIED FEB. 4

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".